Samsung J Women's Clinic Doctor's Column 한국어로 읽기
Obstetrics & Gynecology Column

Reactive Cellular Changes on a Cervical Cytology Result: Is Treatment Needed Straight Away?

What reactive cellular change on a cervical cytology test means, how often to retest, and when an HPV test becomes necessary.

Published 2026-10-23 Updated 2026-10-23 Reviewed by Ji Hyon Suh, Medical Director · Obstetrics & Gynecology Specialist

When a cervical cytology report carries the phrase 'reactive cellular change', it is easy to worry first about whether it means cancer. To give the conclusion first, it is a normal response of the cells to inflammation or irritation, and it is not a disease that needs treatment. This article explains where reactive cellular change sits among the possible results, and when regular screening and an HPV test are needed.

Anxiety often grows when people try to interpret the report on their own, but knowing what each stage means makes it easier to judge when another consultation is needed.

01

What kind of condition is reactive cellular change?

Key point
Reactive cellular change is a finding that appears when cells respond temporarily to inflammation or irritation. It is a benign result, distinct from cancer, and it corresponds to stage 1, the lowest of the four stages used to grade a cervical cytology test, so it is not a disease that needs treatment.

A cervical cytology test grades the degree of abnormality in order: stage 1 reactive cellular change, stage 2 atypical squamous cells, stage 3 squamous intraepithelial lesion and stage 4 cervical cancer. Reactive cellular change can appear from inflammation alone, regardless of any viral infection, so it is classed in a fundamentally different category from cancer and is not a target for treatment.

In data that followed 45 cases, 87.9% of those reported as reactive cellular change had improved at the retest without any particular treatment, and only the remaining 10.2% went on to a finding that needed further observation. This shows that most reactive cellular change is no more than a temporary change, but anyone who receives this result should still keep to the recommended time for the retest.

  • Stage 1 reactive cellular change — a normal response to inflammation or irritation, a benign finding unrelated to cancer
  • Stage 2 atypical squamous cells — the shape of the cells is irregular, so further confirmation such as an HPV test is needed
  • Stage 3 squamous intraepithelial lesion — actual precancerous cell change is observed, so detailed diagnosis is recommended
  • Stage 4 cervical cancer — the stage at which an invasive lesion is confirmed, and a treatment plan is needed immediately
Anatomy illustration related to Reactive Cellular Changes on a Cervical Cytology Result: Is Treatment Needed Straight Away?
02

When should the next test be, and what should you do until then?

Key point
Changes in cervical cells cause almost no symptoms in the early period, so without regular screening they are often found only once they have progressed. For that reason it is important to keep to the recommended screening interval whether or not any symptoms are present.

At the stage of early cell change there are almost no symptoms a person can notice, such as bleeding or pain, and the related viral infection also takes hold in the cervical cells without discomfort. As a result, by the time someone senses that something is wrong and visits a clinic, the change has in many cases already progressed considerably.

Looking at the time taken to reach a confirmed diagnosis, cases found early through regular screening took an average of 2.92 months, whereas cases confirmed at the stage of advanced cancer after symptoms had appeared took an average of 10.5 months, so the time to diagnosis differed widely depending on when screening took place.

Anatomy illustration related to Reactive Cellular Changes on a Cervical Cytology Result: Is Treatment Needed Straight Away?
03

How are the HPV test and the retest interval decided from the cytology result?

Key point
The cytology test and the HPV test look at different things, so neither can replace the other. The retest interval depends on earlier results: if all previous results were normal the cycle is 2 years, and if there was an abnormal finding it becomes 1 year.

The cervical cytology test identifies changes in the shape of the cells, while the HPV test confirms whether the related virus is present, so the two examine different points. If the cytology result is reactive cellular change with no other abnormality, there is little need to add an HPV test straight away at this stage.

If both the cytology test and the HPV test are normal, a retest on a 2 year cycle is recommended; if the HPV test is positive or an earlier result showed an abnormal finding, the recommended cycle is 1 year. Screening generally begins from the age of 20 even without particular symptoms, and it is safer not to lengthen the interval on your own because a result once came back normal.

  • Atypical squamous cells or above — an HPV test is carried out alongside to confirm whether infection is present
  • Repeated reactive cellular change — if the same finding continues at the retest, an HPV test is considered
  • Cytology test and HPV test both normal — regular screening on a 2 year cycle is sufficient
Ji Hyon Suh, Medical Director
Doctor's view

How the doctor decides

Ji Hyon Suh, Medical Director · Obstetrics & Gynecology Specialist

I do not judge by the stage on the report alone

I do not draw a firm conclusion from the result of reactive cellular change by itself. I need to confirm the earlier screening history and whether there are symptoms before I can tell a temporary inflammatory response from a change that should be watched a little longer. So I start with the previous screening records, and we set the time of the next retest together on that basis.

I do not tell a patient to put off screening just because there are no symptoms

I check the date of the last screening before I ask about symptoms. The time to a confirmed diagnosis is 2.92 months when a change is found early and widens to 10.5 months when it is found late, so where the gap between screenings has grown long I recommend screening first, even without symptoms. Checking in that way makes my next advice more accurate.

I do not recommend an HPV test straight away just because there is an abnormal finding

A case with a clear inflammatory cause, such as reactive cellular change, and a case where the cause has to be distinguished, such as atypical squamous cells, call for different approaches. I therefore look at the pattern of cell change first, and recommend an HPV test only where it is needed.

I do not drop the recommended interval because a result came back normal

The figure that 87.9% improve without particular treatment is only an overall tendency and does not promise what an individual patient's next result will be. So after a normal result I still advise the retest on a 2 year cycle as before, and I write down the next due date together with the patient.

Summary

In summary

If you have received a result of reactive cellular change, it is likely to be a temporary response to inflammation or irritation and not cancer. Even so, 10.2% can go on to a finding that needs further confirmation, so it is important to keep to the time of the retest. Regular screening should begin from the age of 20 even without symptoms, and the 1 year or 2 year cycle that fits the earlier results should be kept.

FAQ

Frequently asked questions

QDoes reactive cellular change progress to cervical cancer?
A

Reactive cellular change is a normal response to inflammation or irritation, a benign finding that is different from cervical cancer. Of 45 cases, 87.9% improved without treatment, and only 10.2% needed further confirmation.

QDo I need screening even though I have no symptoms at all?
A

Yes. The time to a confirmed diagnosis is 2.92 months when a change is found early, but lengthens to 10.5 months when it is found after it has progressed, so it is better to check in advance through regular screening even without symptoms.

QHow many years apart should the retest be?
A

If everything is normal, a retest on a 2 year cycle is recommended; if an earlier result was abnormal or the HPV test is positive, a 1 year cycle is recommended. Screening generally begins from the age of 20.

Ji Hyon Suh, Medical Director
Medical review
Ji Hyon Suh, Medical Director · Obstetrics & Gynecology Specialist
This content is general medical information and may not apply to every individual. Diagnosis and treatment are decided through a consultation.
Doctor profile and qualifications